Platelet Accumulation on Collagen: Drugs Which Inhibit Arachidonic Acid Metabolism and Affect Intracellular Cyclic AMP Levels

Summary

We have studied the accumulation of washed platelets on collagen-coated glass from flowing platelet-red blood cell suspensions in the presence and absence of drugs. Glass tubes were 10 cm long and the flow rate was 1 ml/min, 80 s^-1. For all experiments, platelet accumulation was greatest near the tube’s inlet with a continuous decrease to the exit. A common feature, of those drug treatments which lead to reduced accumulation at the inlet, was an increase in outlet accumulation when compared with outlet control values. Platelet-collagen adhesion resulted in maximal release of ³H-serotonin in the presence of agents that prevent platelet aggregation on collagen. Only drug treatment known to raise cAMP levels (PGE₁ and dipyridamole) or prevent the formation of prostaglandins and thromboxanes (sulfinpyrazone, indomethacin and ASA) were found to inhibit aggregate growth. Platelet aggregation on collagen in the absence of thrombin likely proceeds through the liberation of prostaglandins and thromboxanes from surface-bound platelets into the flow where they may stimulate flow-bom cells. An alternate hypothesis is that such treatments affect the release of a-granule components necessary for aggregation.

Keywords

Platelet adhesion - Platelet aggregation - Platelet release - Collagen - Anti-thrombotic drugs

• References

• 1 Mustard JF. Function of blood platelets and their role in thrombosis. Trans Am Clin Climatol Assoc 1976; 87: 104-127
• 2 Mason RG, Mohammed SF, Chuang HY K, Richardson PD. The adhesion of platelets to subendothelium, collagen and artificial surfaces. Sem Thromb Haemostas 1976; 3: 98-116
• 3 Adams GA, Feuerstein IA. Kinetics of platelet adhesion and aggregation on protein-coated surfaces: morphology and release from dense granules. ASAIO J 1982; 4: 90-99
• 4 Adams GA, Feuerstein IA. Platelet adhesion and release: interfacial concentrations of released materials. Am J Physiol 1981; 240: H99-H108
• 5 Adams GA, Feuerstein IA. Platelet adhesion and release: maximum fluid concentrations of materials released from platelets. Am J Physiol 1983; 244: H109-H114
• 6 Marcus AJ. Platelet aggregation. In Haemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VS, Salzman WE. (eds) pp 380-389 JB Lippincott Cox; Toronto: 1982
• 7 Kinlough-Rathbone RL, Packham MA, Reimers H-J, Cazenave J-P, Mustard JF. Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin or A23187. J Lab Clin Med 1977; 90: 707-719
• 8 Holmsen H, Weiss HJ. Secretable storage pools in platelets. Ann Rev Med 1979; 30: 119-134
• 9 Dejana E, Cazenave J-P, Groves HM, Kinlough-Rathbone RL, Richardson M, Packham MA, Mustard JF. The effect of aspirin inhibition of PGI₂ production on platelet adherence to normal and damaged rabbit aortae. Thromb Res 1980; 17: 453-464
• 10 Kinlough-Rathbone RL, Cazenave J-P, Packham MA, Mustard JF. Effect of inhibitors of the arachidonate pathway on release of granule contents from rabbit platelets adherent to collagen. Lab Invest 1980; 42: 28-34
• 11 Baumgartner HR, Muggli R, Tschopp TB, Turitto VT. Platelet adhesion, release, and aggregation in flowing blood: effects of surface properties and platelet function. Thromb Haemostas 1976; 35: 124-138
• 12 Whicher SJ, Brash JL. Platelet-foreign surface interactions: release of granule contents from adherent platelets. J Biomed Mater Res 1978; 12: 181-201
• 13 Marcus AJ. Platelet lipids. In Haemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) pp 474-485 JB Lippincott, Co; Toronto: 1982
• 14 Tschopp TB, Baumgartner HR. Enzymatic removal of ADP from plasma: unaltered platelet adhesion but reduced aggregation on subendothelium and collagen fibrils. Thromb Haemostas 1976; 35: 334-341
• 15 Baumgartner HR. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood. Haemostas 1979; 8: 340-352
• 16 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204
• 17 Cazenave J-P, Packham MA, Mustard JF. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med 1973; 82: 978-990
• 18 Mustard JF, Kinlough-Rathbone RL, Packham MA. Prostaglandins and platelets. Ann Rev Med 1980; 31: 89-96
• 19 Flower RJ, Blackwell GJ. The importance of phospholipase A₂ in prostaglandin biosynthesis. Biochem Pharmacol 1976; 25: 285-291
• 20 Da Prada M, Pletscher A. Accumulation of basic drugs in 5- hydroxytryptamine storage organelles of rabbit blood platelets. Eur J Pharmacol 1975; 32: 179-185
• 21 Winocour PD, Kinlough-Rathbone RL, Mustard JF. The effect of the phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface. Thromb Haemostas 1981; 45: 257-262
• 22 Weiss HJ, Tschopp TB, Baumgartner HR. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage pool disease and after aspirin ingestion. N Eng J Med 1975; 293: 619-623
• 23 Weiss HJ, Turitto VT. Prostacyclin (Prostaglandin I₂, PGI₂) inhibits platelet adhesion and thrombus formation on subendothelium. Blood 1979; 53: 244-250